DeepMed Research

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1969-01-01

Employees: 2K

Market Cap: -

Website: http://www.uab.edu

Clinical Trials

Reducing Care-Resistant Behaviors During Oral Hygiene in Persons With Dementia

Not Applicable

Completed

Conditions: Care-resistant Behavior
Dementia

Interventions: Behavioral: Care-resistant mouth care (MOUTh)
Procedure: Evidence-based mouth care

First Posted Date: 2011-06-01

Last Posted Date: 2018-06-07

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 100

Registration Number: NCT01363258

Locations: 🇺🇸
Centre Crest, Bellefonte, Pennsylvania, United States
🇺🇸
Rest Haven Rehabilitation &Nursing Center, York, Pennsylvania, United States
🇺🇸
Spring Creek Rehabilitation &Health Care Center, Harrisburg, Pennsylvania, United States

and more 1 locations

Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis

Phase 2

Completed

Conditions: Trichomonas Vaginitis

Interventions: Drug: oral metronidazole
Drug: neo penotran forte
Drug: neo penotran forte once a day

First Posted Date: 2011-05-26

Last Posted Date: 2018-01-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 40

Registration Number: NCT01361048

Locations: 🇺🇸
Personal Health Clinic UAB, Birmingham, Alabama, United States

The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication

Not Applicable

Completed

Conditions: Pain Management

Interventions: Other: Interactive DVD
Other: Usual Care

First Posted Date: 2011-05-12

Last Posted Date: 2013-03-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 422

Registration Number: NCT01352832

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects

Phase 4

Terminated

Conditions: Diabetes
Pre-hypertension
Hypertension

Interventions: Drug: aliskiren 300 mg once daily
Drug: Placebo/sugar pill

First Posted Date: 2011-05-06

Last Posted Date: 2017-05-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 21

Registration Number: NCT01349114

Locations: 🇺🇸
UAB, Birmingham, Alabama, United States

Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators

Phase 2

Completed

Conditions: Cystic Fibrosis

Interventions: Other: quercetin

First Posted Date: 2011-05-05

Last Posted Date: 2012-01-31

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 32

Registration Number: NCT01348204

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Resistance Training and Physical Functioning in Head and Neck Cancer Patients

Phase 1

Completed

Conditions: Head and Neck Cancer
Pharyngeal Cancer
Laryngeal Cancer

Interventions: Behavioral: Resistance Training and Nutrition Counseling
Behavioral: Nutrition Counseling

First Posted Date: 2011-04-11

Last Posted Date: 2023-10-18

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 18

Registration Number: NCT01332682

Locations: 🇺🇸
Southern Illinois University School of Medicine, Springfield, Illinois, United States

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension

Phase 4

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: ambrisentan

First Posted Date: 2011-04-06

Last Posted Date: 2014-08-11

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 32

Registration Number: NCT01330108

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

African American Children, Glycemic Control, and Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Vitamin D Deficiency

Interventions: Other: Sugar pill
Dietary Supplement: Vitamin D2

First Posted Date: 2011-03-30

Last Posted Date: 2014-01-20

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 31

Registration Number: NCT01325987

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer

Phase 2

Completed

Conditions: Stage IV Breast Cancer
Breast Cancer
Triple Negative Breast Cancer
Metastatic Breast Cancer

Interventions: Drug: Abraxane alone
Drug: Abraxane + Tigatuzumab

First Posted Date: 2011-03-03

Last Posted Date: 2017-10-26

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 64

Registration Number: NCT01307891

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Baylor University, Houston, Texas, United States

and more 7 locations

Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient

Phase 4

Completed

Conditions: Cigarette Smoking
Home Access to Internet and Email
Cognitively and Physically Able to Participate
English Speaking and Reading

Interventions: Behavioral: Web-based smoking cessation program

First Posted Date: 2011-01-14

Last Posted Date: 2015-06-19

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 1548

Registration Number: NCT01277250

Locations: 🇺🇸
The University of Alabama at Birmingham - Lung Health Center, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy